Product Code: LI_2113940 / A13571
The global thyroid ablation devices market was valued at $472.79 million in 2020, and is estimated to reach $1,294.43 million by 2030, growing at a CAGR of 10.6% from 2021 to 2030. Thyroid ablation is a procedure done to restore the function of thyroid gland while suffering from thyroid cancer or thyroid nodules. Thyroid is located at lower front position of the neck and it is a butterfly shaped. An active thyroid gland and too much hormone may need thyroid ablation as treatment to address medical problems such as thyroid nodules and thyroid cancer. It is a procedure done to decrease the function of thyroid gland.
Growth of the global thyroid ablation devices market is majorly driven by alarming increase in prevalence of thyroid diseases, such as thyroid nodules and thyroid cancer; rise in government initiatives for development of pharmaceutical and medical device industry; increase in number of approvals for thyroid ablation devices product; and development of advanced thyroid ablation devices product. According to the Saint John's Cancer Institute thyroid radiofrequency ablation is a non-surgical treatment option, which can reduce size of thyroid nodule. It reduces the need for nodule surgery and use of radioactive iodine. Moreover, as per the American Cancer Society Statistics 2021, in U.S, there were about 44,280 new cases of thyroid cancer, out of which 12,150 were in men and 32,130 in women. Furthermore, in June 2021, Boston Scientific acquired FARAPULSE for its electrophysiology segment which brings pulsed-field ablation technology to its portfolio. Thus, advancements in technology for advanced thyroid ablation devices products in emerging nations and urinary are expected to propel growth of the market.
Increase in government support for management of Hashimoto's thyroiditis and surge in demand for effective treatment are the major factors that drive the global thyroid ablation devices market. In addition, key players such as Sonacare Medical and Theraclion, which provide numerous ablation products for treatment of thyroid cancer contributes toward the market growth. Rise in demand for ablation devices for treatment of thyroid nodules act a key driving force for expansion of the global market.
However, high cost associated with thyroid ablation devices products for treatment of Hashimoto's disease is anticipated to hinder the market growth. People, nowadays are more aware of health, which, in turn, compels them to maintain their health condition and increase demand for thyroid ablation devices product. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the thyroid ablation devices market.
The global thyroid ablation devices market is segmented into type, application, end user, and region. By type, the market is categorized into image guided ablation, radiofrequency ablation, microwave ablation, and others.
Depending on application, it is fragmented into thyroid nodules and thyroid cancer. As per end user, it is divided into hospitals & clinics, ambulatory surgical centers, cancer specialty centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global thyroid ablation devices market are Boston Scientific Corporation, BVM Medical System, Integra Life Sciences, Johnson & Johnson, Medtronic Plc., MedWaves Inc., Olympus Corporation, StarMed Co.Ltd., Terumo Europe, and Theraclion.
.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global thyroid ablation market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product Type
- Image-guided Ablation
- Radiofrequency Ablation
- Microwave Ablation
- Others
By Application
- Thyroid Cancer
- Thyroid Nodules
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cancer Specialty Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Boston Scientific Corporation
- BVM Medical System
- Integra Life Sciences
- Johnson & Johnson
- Medtronic Plc.
- MedWaves Inc.
- Olympus Corporation
- StarMed Co.Ltd.
- Terumo Europe
- Theraclion
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
Key benefits for stakeholders
- 1.2.Key market segments
- 1.3.Research methodology
- 1.3.1.Secondary research
- 1.3.2.Primary research
- 1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE.
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.2.2.Top winning strategies
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning, 2020
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.1.1.Increase in prevalence of thyroid cancer and thyroid nodules
- 3.5.1.2.Increasing demand for minimally invasive procedures
- 3.5.1.3.Technological advancements in ablation devices
- 3.5.2.Restraint
- 3.5.2.1.High cost of installation and maintenance
- 3.5.3.Opportunity
- 3.5.3.1.Increase in healthcare expenditure worldwide
- 3.5.4.Impact analysis
- 3.6.Impact analysis of COVID-19 on the thyroid ablation devices market
CHAPTER 4:THYROID ABLATION DEVICES MARKET, BY TYPE
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Image-guided Ablation
- 4.2.1.Key market trends, growth factors, and opportunities
- 4.2.2.Market size and forecast, by region
- 4.2.3.Market analysis, by country
- 4.3.Radiofrequency Ablation
- 4.3.1.Key market trends, growth factors, and opportunities
- 4.3.2.Market size and forecast, by region
- 4.3.3.Market analysis, by country
- 4.4.Microwave Ablation
- 4.4.1.Key market trends, growth factors, and opportunities
- 4.4.2.Market size and forecast, by region
- 4.4.3.Market analysis, by country
- 4.5.Others
- 4.5.1.Key market trends, growth factors, and opportunities
- 4.5.2.Market size and forecast, by region
- 4.5.3.Market analysis, by country
CHAPTER 5:THYROID ABLATION DEVICES MARKET, BY APPLICATION
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Thyroid Cancer
- 5.2.1.Market size and forecast, by region
- 5.2.2.Market analysis, by country
- 5.3.Thyroid Nodules
- 5.3.1.Market size and forecast, by region
- 5.3.2.Market analysis, by country
CHAPTER 6:THYROID ABLATION DEVICES MARKET, BY END USER
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.Hospitals & Clinics
- 6.2.1.Market size and forecast, by region
- 6.2.2.Market analysis, by country
- 6.3.Ambulatory Surgical Centers
- 6.3.1.Market size and forecast, by region
- 6.3.2.Market analysis, by country
- 6.4.Cancer Specialty Centers
- 6.4.1.Market size and forecast, by region
- 6.4.2.Market analysis, by country
- 6.5.Others (Cancer research center and R & D companies)
- 6.5.1.Market size and forecast, by region
- 6.5.2.Market analysis, by country
CHAPTER 7:THYROID ABLATION DEVICES MARKET, BY REGION
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.North America
- 7.2.1.Key market trends, growth factors, and opportunities
- 7.2.2.North America thyroid ablation devices market, by type
- 7.2.3.North America thyroid ablation devices market, by application
- 7.2.4.North America thyroid ablation devices market, by end user
- 7.2.5.Market size and forecast, by country
- 7.2.5.1.U.S.
- 7.2.5.1.1.U.S. thyroid ablation devices market, by type
- 7.2.5.1.2.U.S. thyroid ablation devices market, by application
- 7.2.5.1.3.U.S. thyroid ablation devices market, by end user
- 7.2.5.2.Canada
- 7.2.5.2.1.Canada thyroid ablation devices market, by type
- 7.2.5.2.2.Canada thyroid ablation devices market, by application
- 7.2.5.2.3.Canada thyroid ablation devices market, by end user
- 7.2.5.3.Mexico
- 7.2.5.3.1.Mexico thyroid ablation devices market, by type
- 7.2.5.3.2.Mexico thyroid ablation devices market, by application
- 7.2.5.3.3.Mexico thyroid ablation devices market, by end user
- 7.3.Europe
- 7.3.1.Key market trends, growth factors, and opportunities
- 7.3.2.Europe thyroid ablation devices market, by type
- 7.3.3.Europe thyroid ablation devices market, by application
- 7.3.4.Europe thyroid ablation devices market, by end user
- 7.3.5.Market size and forecast, by country
- 7.3.5.1.Germany
- 7.3.5.1.1.Germany thyroid ablation devices market, by type
- 7.3.5.1.2.Germany thyroid ablation devices market, by application
- 7.3.5.1.3.Germany thyroid ablation devices market, by end user
- 7.3.5.2.France
- 7.3.5.2.1.France thyroid ablation devices market, by type
- 7.3.5.2.2.France thyroid ablation devices market, by application
- 7.3.5.2.3.France thyroid ablation devices market, by end user
- 7.3.5.3.UK
- 7.3.5.3.1.UK thyroid ablation devices market, by type
- 7.3.5.3.2.UK thyroid ablation devices market, by application
- 7.3.5.3.3.UK thyroid ablation devices market, by end user
- 7.3.5.4.Italy
- 7.3.5.4.1.Italy thyroid ablation devices market, by type
- 7.3.5.4.2.Italy thyroid ablation devices market, by application
- 7.3.5.4.3.Italy thyroid ablation devices market, by end user
- 7.3.5.5.Spain
- 7.3.5.5.1.Spain thyroid ablation devices market, by type
- 7.3.5.5.2.Spain thyroid ablation devices market, by application
- 7.3.5.5.3.Spain thyroid ablation devices market, by end user
- 7.3.5.6.Rest of Europe
- 7.3.5.6.1.Rest of Europe thyroid ablation devices market, by type
- 7.3.5.6.2.Rest of Europe thyroid ablation devices market, by application
- 7.3.5.6.3.Rest of Europe thyroid ablation devices market, by end user
- 7.4.Asia-Pacific
- 7.4.1.Key market trends, growth factors, and opportunities
- 7.4.2.Asia-Pacific thyroid ablation devices market, by type
- 7.4.3.Asia-Pacific thyroid ablation devices market, by application
- 7.4.4.Asia-Pacific thyroid ablation devices market, by end user
- 7.4.5.Market size and forecast, by country
- 7.4.5.1.Japan
- 7.4.5.1.1.Japan thyroid ablation devices market, by type
- 7.4.5.1.2.Japan thyroid ablation devices market, by application
- 7.4.5.1.3.Japan thyroid ablation devices market, by end user
- 7.4.5.2.China
- 7.4.5.2.1.China thyroid ablation devices market, by type
- 7.4.5.2.2.China thyroid ablation devices market, by application
- 7.4.5.2.3.China thyroid ablation devices market, by end user
- 7.4.5.3.Australia
- 7.4.5.3.1.Australia thyroid ablation devices market, by type
- 7.4.5.3.2.Australia thyroid ablation devices market, by application
- 7.4.5.3.3.Australia thyroid ablation devices market, by end user
- 7.4.5.4.India
- 7.4.5.4.1.India thyroid ablation devices market, by type
- 7.4.5.4.2.India thyroid ablation devices market, by application
- 7.4.5.4.3.India thyroid ablation devices market, by end user
- 7.4.5.5.South Korea
- 7.4.5.5.1.South Korea thyroid ablation devices market, by type
- 7.4.5.5.2.South Korea thyroid ablation devices market, by application
- 7.4.5.5.3.South Korea thyroid ablation devices market, by end user
- 7.4.5.6.Rest of Asia-Pacific
- 7.4.5.6.1.Rest of Asia-Pacific thyroid ablation devices market, by type
- 7.4.5.6.2.Rest of Asia-Pacific thyroid ablation devices market, by application
- 7.4.5.6.3.Rest of Asia-Pacific thyroid ablation devices market, by end user
- 7.5.LAMEA
- 7.5.1.Key market trends, growth factors, and opportunities
- 7.5.2.LAMEA thyroid ablation devices market, by type
- 7.5.3.LAMEA thyroid ablation devices market, by application
- 7.5.4.LAMEA thyroid ablation devices market, by end user
- 7.5.5.Market size and forecast, by country
- 7.5.5.1.Latin America
- 7.5.5.1.1.Latin America thyroid ablation devices market, by type
- 7.5.5.1.2.Latin America thyroid ablation devices market, by application
- 7.5.5.1.3.Latin America thyroid ablation devices market, by end user
- 7.5.5.2.Middle East and Africa
- 7.5.5.2.1.Middle East and Africa thyroid ablation devices market, by type
- 7.5.5.2.2.Middle East and Africa thyroid ablation devices market, by application
- 7.5.5.2.3.Middle East and Africa thyroid ablation devices market, by end user
CHAPTER 8:COMPANY PROFILES
- 8.1.BOSTON SCIENTIFIC CORPORATION
- 8.1.1.Company overview
- 8.1.2.Company snapshot
- 8.1.3.Operating business segments
- 8.1.4.Product portfolio
- 8.1.5.Business performance
- 8.2.BVM MEDICAL SYSTEM
- 8.2.1.Company overview
- 8.2.2.Company snapshot
- 8.2.3.Operating business segments
- 8.2.4.Product portfolio
- 8.2.5.Key strategic moves and developments
- 8.3.INTEGRA LIFE SCIENCES
- 8.3.1.Company overview
- 8.3.2.Company snapshot
- 8.3.3.Operating business segments
- 8.3.4.Product portfolio
- 8.3.5.Business performance
- 8.4.JOHNSON & JOHNSON (ETHICON)
- 8.4.1.Company overview
- 8.4.2.Company snapshot
- 8.4.3.Operating business segments
- 8.4.4.Product portfolio
- 8.4.5.Business performance
- 8.4.6.Key strategic moves and developments
- 8.5.MEDTRONIC PLC
- 8.5.1.Company overview
- 8.5.2.Company snapshot
- 8.5.3.Operating business segments
- 8.5.4.Product portfolio
- 8.5.5.Business performance
- 8.5.6.Key strategic moves and developments
- 8.6.MEDWAVES INC.
- 8.6.1.Company overview
- 8.6.2.Company snapshot
- 8.6.3.Operating business segments
- 8.6.4.Product portfolio
- 8.7.OLYMPUS CORPORATION
- 8.7.1.Company overview
- 8.7.2.Company snapshot
- 8.7.3.Operating business segments
- 8.7.4.Product portfolio
- 8.7.5.Business performance
- 8.8.STARMED CO.LTD.
- 8.8.1.Company overview
- 8.8.2.Company snapshot
- 8.8.3.Product portfolio
- 8.9.TERUMO CORPORATION (TERUMO EUROPE)
- 8.9.1.Company overview
- 8.9.2.Company snapshot
- 8.9.3.Operating business segments
- 8.9.4.Product portfolio
- 8.9.5.Business performance
- 8.9.6.Key strategic moves and developments
- 8.10.THERACLION
- 8.10.1.Company overview
- 8.10.2.Company snapshot
- 8.10.3.Operating business segments
- 8.10.4.Product portfolio